Article Figures & Data
Figures
Tables
Data Supplement
- Supplemental Data -
Supplementary Methods
Supplementary Table 1 - Mean concentration-time data for oral fevipiprant and its AG metabolite without
cyclosporine and with cyclosporine.Supplementary Table 2 - Geometric mean ratio (test/reference) and 90% confidence intervals for PK parameters of oral fevipipran.
Supplementary Table 3 - Mean concentration-time data for fevipiprant 100 μg IV without and with cyclosporine.
Supplementary Table 4 - Geometric mean ratio (test/reference) and 90 percent confidence intervals for PK
parameters of IV administered fevipiprant ([13C2 15N2]fevipiprant).Supplementary Table 5 - Geometric mean ratio (test/reference) and 90% confidence intervals for PK parameters for the AG metabolite.
Supplementary Table 6 - Incidence of adverse events by preferred term (Safety analysis set).
- Supplemental Data -